AU2008270247A1 - Pirenzepine and derivatives thereof as anti-amyloid agents - Google Patents
Pirenzepine and derivatives thereof as anti-amyloid agents Download PDFInfo
- Publication number
- AU2008270247A1 AU2008270247A1 AU2008270247A AU2008270247A AU2008270247A1 AU 2008270247 A1 AU2008270247 A1 AU 2008270247A1 AU 2008270247 A AU2008270247 A AU 2008270247A AU 2008270247 A AU2008270247 A AU 2008270247A AU 2008270247 A1 AU2008270247 A1 AU 2008270247A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- halo
- alkyl
- amyloid
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07111491 | 2007-07-02 | ||
| EP07111491.2 | 2007-07-02 | ||
| PCT/EP2008/058527 WO2009004038A2 (en) | 2007-07-02 | 2008-07-02 | Therapeutic compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008270247A1 true AU2008270247A1 (en) | 2009-01-08 |
| AU2008270247A2 AU2008270247A2 (en) | 2010-01-28 |
Family
ID=40020257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008270247A Abandoned AU2008270247A1 (en) | 2007-07-02 | 2008-07-02 | Pirenzepine and derivatives thereof as anti-amyloid agents |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100247688A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2173355A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010531854A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100038424A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101778634A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008270247A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0812849A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2691844A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL202768A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009014126A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ582314A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2010103105A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009004038A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2387405A2 (en) | 2009-01-13 | 2011-11-23 | ProteoSys AG | Pirenzepine as an agent in cancer treatment |
| ES2693152T3 (es) * | 2011-05-10 | 2018-12-07 | Kyowa Hakko Kirin Co., Ltd. | Compuesto de pirimido-diazepinona |
| WO2013068592A1 (en) * | 2011-11-10 | 2013-05-16 | Fondation Jerome Lejeune | Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide |
| CN116635034A (zh) * | 2020-09-22 | 2023-08-22 | K·E·克拉伦斯-史密斯 | 用于治疗人低胆碱能障碍的药物组合 |
| CA3192987A1 (en) * | 2020-09-22 | 2022-03-31 | Kathleen E. Clarence-Smith | Pharmaceutical combination for the treatment of human hypocholinergic disorders |
| WO2023137098A1 (en) * | 2022-01-16 | 2023-07-20 | Winsantor, Inc. | Compositions and methods for improving sexual sensory disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795183B1 (de) * | 1968-08-20 | 1972-07-20 | Thomae Gmbh Dr K | 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel |
| DE3818299A1 (de) * | 1988-05-30 | 1989-12-07 | Thomae Gmbh Dr K | Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4112014A1 (de) * | 1991-04-12 | 1992-10-15 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung |
| EP1781300A1 (en) * | 2004-07-16 | 2007-05-09 | ProteoSys AG | Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases |
| MX2008000461A (es) * | 2005-07-12 | 2008-03-10 | Abbott Gmbh & Co Kg | Compuestos de piridazina como inhibidores de la glucogeno sintasa cinasa 3. |
-
2008
- 2008-07-02 RU RU2010103105/15A patent/RU2010103105A/ru not_active Application Discontinuation
- 2008-07-02 KR KR1020107002421A patent/KR20100038424A/ko not_active Withdrawn
- 2008-07-02 EP EP08774661A patent/EP2173355A2/en not_active Withdrawn
- 2008-07-02 US US12/667,445 patent/US20100247688A1/en not_active Abandoned
- 2008-07-02 WO PCT/EP2008/058527 patent/WO2009004038A2/en not_active Ceased
- 2008-07-02 CN CN200880103247A patent/CN101778634A/zh active Pending
- 2008-07-02 CA CA002691844A patent/CA2691844A1/en not_active Abandoned
- 2008-07-02 MX MX2009014126A patent/MX2009014126A/es not_active Application Discontinuation
- 2008-07-02 AU AU2008270247A patent/AU2008270247A1/en not_active Abandoned
- 2008-07-02 BR BRPI0812849-9A2A patent/BRPI0812849A2/pt not_active IP Right Cessation
- 2008-07-02 JP JP2010513980A patent/JP2010531854A/ja not_active Withdrawn
- 2008-07-02 NZ NZ582314A patent/NZ582314A/en not_active IP Right Cessation
-
2009
- 2009-12-16 IL IL202768A patent/IL202768A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100247688A1 (en) | 2010-09-30 |
| JP2010531854A (ja) | 2010-09-30 |
| KR20100038424A (ko) | 2010-04-14 |
| WO2009004038A2 (en) | 2009-01-08 |
| BRPI0812849A2 (pt) | 2014-12-09 |
| IL202768A0 (en) | 2010-06-30 |
| NZ582314A (en) | 2012-04-27 |
| MX2009014126A (es) | 2010-03-29 |
| CA2691844A1 (en) | 2009-01-08 |
| RU2010103105A (ru) | 2011-08-10 |
| WO2009004038A3 (en) | 2009-11-26 |
| AU2008270247A2 (en) | 2010-01-28 |
| EP2173355A2 (en) | 2010-04-14 |
| CN101778634A (zh) | 2010-07-14 |
| WO2009004038A8 (en) | 2010-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018250214B2 (en) | Methods and compositions for treating aging-associated impairments using CCR3-inhibitors | |
| US11642352B2 (en) | Methods of treating wandering in Lewy dody dementia | |
| WO2012047587A2 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
| WO2018136600A1 (en) | Use of pridopidine for the treatment of fragile x syndrome | |
| EP2420235A1 (en) | Methods and combination therapies for treating alzheimer's disease | |
| US20100247688A1 (en) | Pirenzepine and derivatives thereof as anti-amyloid agents | |
| EP4087564B1 (en) | Fasudil for use in methods of treating alzheimer's dementia associated wandering | |
| CN102984938A (zh) | 轻度认知障碍(mci)和阿尔茨海默氏症的治疗方法 | |
| US9968574B2 (en) | Treatment of MCI and Alzheimer's disease | |
| WO2005118582A1 (ja) | アミド化合物を含有する角膜知覚回復剤 | |
| CN107709326A (zh) | 降低应激诱导的p‑tau的三唑并吡啶和三唑并嘧啶 | |
| KR20210065950A (ko) | Ccr3-억제제를 사용한 노화 관련 장애 치료를 위한 방법 및 조성물 | |
| CA3111433C (en) | Methods and compositions for treating aging-associated impairments using ccr3-inhibitors | |
| HK1145641A (en) | Pirenzepine and derivatives thereof as anti-amyloid agents | |
| ES3062815T3 (en) | Compositions for treating aging-associated impairments using ccr3-inhibitors | |
| CN121941686A (zh) | 用于治疗神经退行性疾病的融合杂环 | |
| KR20260049797A (ko) | 경도 인지 장애 치료를 위한 병용 요법의 치료제 조성물 및 사용 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 23 DEC 2009 |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |